During the past decade, Connecticut Clinical Research Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 14 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Connecticut Clinical Research Center" #1 sponsor was "Ferring Pharmaceuticals" with 7 trials, followed by "Clarus Therapeutics, Inc." with 2 trials sponsored, "Endo Pharmaceuticals" with 2 trials sponsored, "Spectrum Pharmaceuticals, Inc" with 2 trials sponsored and "Allergan" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Connecticut Clinical Research Center" #1 collaborator was "Allergan" with 1 trials as a collaborator, "Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center" with 1 trials as a collaborator and "PharmaNet" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Connecticut Clinical Research Center" are "Male Hypogonadism" (3 trials), "Nocturia" (3 trials), "Prostate Cancer" (3 trials), "Adult Male Hypogonadism" (2 trials) and "Bladder Cancer" (2 trials). Many other conditions were trialed in "Connecticut Clinical Research Center" in a lesser frequency.

Most popular intervention types in "Connecticut Clinical Research Center" are "Drug" (18 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Apaziquone" (2 trials), "Degarelix" (2 trials), "Oral testosterone undecanoate" (2 trials) and "AA4500" (1 trials). Other intervention names were less common.

The vast majority of trials in "Connecticut Clinical Research Center" are 13 trials for "Male" genders, 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Connecticut Clinical Research Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Connecticut Clinical Research Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Connecticut Clinical Research Center, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".